1. Archbold, E., Mitchel, S., Hanson, D., Hull, B., Galo, L. M., and Monzon, O. (1991). Serum-pooling strategies for HIV screening: Experiences in Trinidad, Ecuador, and the Phillippines. VII International Conference on AIDS Abstract Book, 2, 331.
2. Babu, P. G., Saraswathi, N. K., Vaidyanathan, H., and John, T. J. (1993). Reduction of the cost of testing for antibody to human immunodeficiency virus, without losing sensitivity, by pooling sera. Indian Journal of Medical Research Section A—Infectious Diseases, 97, 1–3.
3. Banks, M. (2000). Automation and technology for HTS in drug development. In Approaches to High Throughput Toxicity Screening. Editors: C. K. Atterwill, P. Goldfarb, and W. Purcell, pages 9–29. Taylor and Francis, London.
4. Behets, F., Bertozzi, S., Kasali, M., Kashamuka, M., Atikala, L., Brown, C., Ryder, R. W., and Quinn, T. C. (1990). Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost efficiency models. AIDS, 4, 737–741.
5. Berenbaum, M. C. (1989). What is synergy? Pharmacological Reviews, 41, 93–141.